Tissue Regenix Group PLC
LSE:TRX
Tissue Regenix Group PLC
LSE:TRX
Price:
0.0725
GBX
Market Cap:
£5.2m
Balance Sheet
Balance Sheet Decomposition
Tissue Regenix Group PLC
Tissue Regenix Group PLC
Balance Sheet Decomposition is not available for
Tissue Regenix Group PLC
Tissue Regenix Group PLC
Balance Sheet
Tissue Regenix Group PLC
Tissue Regenix Group PLC
Currency: USD
| Jan-2008 | Jan-2009 | Jan-2010 | Jan-2011 | Jan-2012 | Jan-2013 | Jan-2014 | Jan-2015 | Jan-2016 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
3
|
3
|
2
|
6
|
28
|
24
|
18
|
10
|
20
|
9
|
20
|
10
|
3
|
12
|
8
|
6
|
5
|
2
|
|
| Cash Equivalents |
3
|
3
|
2
|
6
|
28
|
24
|
18
|
10
|
20
|
9
|
20
|
10
|
3
|
12
|
8
|
6
|
5
|
2
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
3
|
4
|
5
|
4
|
3
|
4
|
5
|
4
|
4
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
2
|
2
|
3
|
4
|
3
|
4
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
3
|
3
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
4
|
3
|
5
|
9
|
10
|
11
|
10
|
14
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
3
|
3
|
2
|
6
|
28
|
25
|
20
|
12
|
22
|
14
|
29
|
18
|
12
|
25
|
22
|
22
|
19
|
21
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
4
|
3
|
3
|
7
|
9
|
9
|
9
|
8
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
4
|
3
|
3
|
7
|
9
|
9
|
9
|
8
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
4
|
4
|
4
|
4
|
5
|
5
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
6
|
3
|
3
|
3
|
3
|
4
|
4
|
|
| Goodwill |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
18
|
19
|
19
|
11
|
12
|
12
|
12
|
12
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
18
|
19
|
19
|
11
|
12
|
12
|
12
|
12
|
|
| Total Assets |
5
N/A
|
3
-48%
|
2
-9%
|
6
+178%
|
29
+341%
|
25
-12%
|
20
-20%
|
13
-37%
|
23
+83%
|
16
-33%
|
56
+259%
|
46
-18%
|
37
-19%
|
45
+21%
|
46
+2%
|
46
0%
|
43
-6%
|
45
+5%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
2
|
1
|
3
|
3
|
1
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
3
|
2
|
2
|
3
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
6
|
5
|
4
|
4
|
4
|
7
|
5
|
6
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
6
|
8
|
8
|
9
|
10
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
0
-25%
|
0
+733%
|
1
+160%
|
1
+6%
|
1
+60%
|
1
-1%
|
2
+71%
|
2
+14%
|
7
+235%
|
6
-21%
|
6
+15%
|
10
+57%
|
12
+16%
|
15
+24%
|
13
-11%
|
16
+19%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
1
|
1
|
1
|
2
|
3
|
3
|
3
|
3
|
4
|
4
|
7
|
7
|
7
|
14
|
16
|
16
|
16
|
16
|
|
| Retained Earnings |
0
|
2
|
3
|
5
|
7
|
11
|
16
|
24
|
33
|
49
|
65
|
73
|
82
|
96
|
116
|
119
|
120
|
120
|
|
| Additional Paid In Capital |
4
|
4
|
4
|
9
|
32
|
32
|
32
|
32
|
50
|
58
|
106
|
106
|
106
|
116
|
134
|
134
|
134
|
134
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
5
N/A
|
3
-48%
|
2
-9%
|
6
+170%
|
28
+348%
|
24
-12%
|
19
-22%
|
12
-39%
|
21
+84%
|
14
-37%
|
49
+263%
|
41
-17%
|
31
-24%
|
35
+14%
|
34
-2%
|
31
-9%
|
30
-4%
|
30
-1%
|
|
| Total Liabilities & Equity |
5
N/A
|
3
-48%
|
2
-9%
|
6
+178%
|
29
+341%
|
25
-12%
|
20
-20%
|
13
-37%
|
23
+83%
|
16
-33%
|
56
+259%
|
46
-18%
|
37
-19%
|
45
+21%
|
46
+2%
|
46
0%
|
43
-6%
|
45
+5%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
120
|
120
|
120
|
469
|
652
|
653
|
653
|
654
|
760
|
760
|
1 171
|
1 172
|
1 172
|
70
|
70
|
70
|
71
|
71
|
|
Switch to:
Switch to:
See Also
Discover More
